Carisma Therapeutics Inc. Undistributed Earnings (Loss) Allocated to Participating Securities, Basic
Carisma Therapeutics Inc. reported Undistributed Earnings (Loss) Allocated to Participating Securities, Basic of $15.00 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic · last filed 2022-11-07
- Carisma Therapeutics Inc. undistributed earnings (loss) allocated to participating securities, basic for the quarter ending 2022-09-30 was $15.00K, a 71.15% decline year-over-year.
- Carisma Therapeutics Inc. undistributed earnings (loss) allocated to participating securities, basic for the quarter ending 2021-09-30 was $52.00K.
- Carisma Therapeutics Inc. undistributed earnings (loss) allocated to participating securities, basic for the quarter ending 2021-06-30 was $0.00.
- Carisma Therapeutics Inc. undistributed earnings (loss) allocated to participating securities, basic for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
| Period end | Undistributed Earnings (Loss) Allocated to Participating Securities, Basic 3 month | Undistributed Earnings (Loss) Allocated to Participating Securities, Basic 6 month | Undistributed Earnings (Loss) Allocated to Participating Securities, Basic 6 month as first filed | Undistributed Earnings (Loss) Allocated to Participating Securities, Basic 9 month |
|---|---|---|---|---|
| 2022-09-30 | $15.00K 10-Q · filed 2022-11-07 | $0.00 10-Q · filed 2022-11-07 | ||
| 2021-09-30 | $52.00K 10-Q · filed 2022-11-07 | $52.00K derived: sum of 2 quarters · filed 2022-11-07 | $0.00 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 | $0.00 10-Q · filed 2021-08-09 | ||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-10 | |||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-08 | $0.00 derived: sum of 2 quarters · filed 2021-11-08 | $0.00 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-09 | $322.00K 10-Q · filed 2021-08-09 | -$322.00K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $7.16M 10-Q · filed 2021-05-10 | |||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-11 |